Specifically, Table 3 demonstrates that patients with high MMP1 expression had a higher risk of poor outcomes in terms of DSS, with an HR of 2.034 (95% CI: 1.183–3.498, p = 0.010), serving as an independently prognostic factor for HR + BC. Here, MMP1 is linked to breast cancer.